Increasing antimicrobial resistance and medical device-related infections have led to a
renewed interest in phage therapy as an alternative or adjunct to conventional …

Biothermodynamics of viruses is among the youngest but most rapidly developing scientific
disciplines. During the COVID-19 pandemic, it closely followed the results published by …

Infections caused by multidrug-resistant (MDR) bacteria have highlighted the importance of
the development of new antimicrobial agents. While bacteriophages (phages) are widely …

SARS-CoV-2 resembles the ancient mythical creature Hydra. Just like with the Hydra, when
one head is cut, it is followed by appearance of two more heads, suppression of one SARS …

In recent years, bacteriophages (or phages) have reentered the spotlight as alternative or
adjuvant therapeutic agents to antibiotics. Their efficacy in more recalcitrant forms of …

Objectives Interest in phages as adjunctive therapy to treat difficult infections has grown in
the last decade. However, phage dosing and delivery for orthopedic infections have not …

Phage-antibiotic synergy (PAS) has been extensively explored over the past decade, with
the aim of developing more effective treatments against multidrug-resistant organisms …

Emergence of multiple drug resistant (MDR) strains of Acinetobacter baumannii and a
withering drug discovery pipeline necessitates the search for effective alternatives to replace …

Staphylococcus aureus is a notorious foodborne pathogen capable of producing various
toxins including heat-stable enterotoxin, forming biofilm, evolving to multidrug-resistant …

In the last three decades, the appearance and rapid diffusion of antibiotic-resistant bacterial
strains have been observed. Contextually, the discovery rate of novel antibacterial agents …